交易中 09-20 15:27:46 美东时间
-0.030
-0.22%
A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the €432...
09-03 19:10
在与欧盟委员会就Grail收购交易案得诉讼中,欧盟最高法院支持Illumina。
09-03 17:25
MENLO PARK, Calif., Aug. 30, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...
08-31 05:55
After Tuesday's closing bell, GRAIL (NASDAQ:GRAL) said it would focus its resources going forward on its core multi-cancer early detection programs, resulting in a 30% reduction in headcount. In addit...
08-14 05:19
GRAIL shares are trading higher. The company Q2 financial results.
08-14 04:55
MENLO PARK, Calif., July 31, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will ...
08-01 04:05
经过3年挣扎与拉扯,Illumina却最终在去年12月17日宣布将Grail剥离。而这家曾经的独角兽也开始了迟到4年的美股IPO并于今年6月25日正式登陆纳斯达克,然后给投资者上演了一出“首日大跌近20%”的戏码。
06-27 11:00
从生命科学公司Illumina分拆出来的癌症检测产品供应商Grail于周二在纳斯达克上市。
06-25 21:27
GRAIL (GRAL) will begin trading on the Nasdaq as a publicly-listed independent company on Tuesday, after Illumina (NASDAQ:ILMN) completed the spinoff of the cancer test developer following regulatory ...
06-25 19:36
Illumina spins off Grail, making Grail an independent public company. Shareholders receive one GRAIL share per six Illumina shares. Illumina retains a 14.5% stake.
06-25 19:17